Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C5H9NO3 |
Molecular Weight | 131.1299 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@H]1CN[C@@H](C1)C(O)=O
InChI
InChIKey=PMMYEEVYMWASQN-DMTCNVIQSA-N
InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m1/s1
HYDROXYPROLINE, a hydroxylated form of the imino acid proline, is a major component of the protein collagen. For this reason, HYDROXYPROLINE content in biological fluids is used as a parameter of collagen catabolism, especially bone resorption or tissue degradation. A deficiency in ascorbic acid can result in impaired HYDROXYPROLINE formation.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Studies on bound trans-4-hydroxy-L-proline in sandal (Santalum album L.). | 1970 Oct |
|
Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with Paget's disease of bone and carcinoma with metastases in bone. | 1979 Mar 15 |
|
A criterion to determine whether cis-4-hydroxyproline is produced in animal tissues. | 1984 Mar |
|
Hydroxyproline and total protein levels in gingiva and gingival crevicular fluid in periodontally healthy human subjects. | 1992 Sep |
|
Hydroxyproline and total protein levels in gingiva and gingival crevicular fluid in patients with juvenile, rapidly progressive, and adult periodontitis. | 1993 May |
|
Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis. | 1996 Jul |
|
Hydroxyproline and total protein levels in gingiva from patients treated with phenytoin and cyclosporine-A. | 1996 Mar |
|
Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. | 1997 Jul |
|
Measurement of histidinohydroxylysinonorleucine and hydroxyproline in skin collagen by reversed-phase high-performance liquid chromatography after 9-fluorenylmethyl chloroformate labeling. | 1997 Oct 15 |
|
Basic principles and clinical applications of biochemical markers of bone metabolism: biochemical and technical aspects. | 1999 Fall |
|
Norplant((R)) implants and progesterone vaginal rings do not affect maternal bone turnover and density during lactation and after weaning. | 1999 Oct |
|
Enzymatic production of trans-4-hydroxy-L-proline by regio- and stereospecific hydroxylation of L-proline. | 2000 Apr |
|
Preparation of functionalized, conformationally constrained DTPA analogues from L- or D-serine and trans-4-hydroxy-L-proline. Hydroxymethyl substituents on the central acetic acid and on the backbone. | 2000 Jun 30 |
|
The importance of the N-terminal beta-turn in bradykinin antagonists. | 2000 Oct |
|
The synthesis of 4-arylsulfanyl-substituted kainoid analogues from trans-4-hydroxy-L-proline. | 2000 Sep 4 |
|
Oxaceprol, an atypical inhibitor of inflammation, reduces leukocyte adherence in mouse antigen-induced arthritis. | 2001 Jun |
|
Pharmacologic pain treatment of musculoskeletal disorders: current perspectives and future prospects. | 2001 Mar |
|
Biochemical measurements in the prediction of histologic subtype of renal transplant bone disease in women. | 2002 Aug |
|
[Meta-analysis of the efficacy of adenosylmethionine and oxaceprol in the treatment of osteoarthritis]. | 2002 Nov |
|
Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. | 2002 Sep |
|
Substituted 2-azabicyclo[2.1.1]hexanes as constrained proline analogues: implications for collagen stability. | 2004 Dec 10 |
|
O-acylation of hydroxyproline residues: effect on peptide-bond isomerization and collagen stability. | 2005 |
|
Effects of dietary conjugated linoleic acid on production and metabolic parameters in transition dairy cows grazing fresh pasture. | 2006 Aug |
|
Oxaceprol--a randomised, placebo-controlled clinical study in osteoarthritis with a non-conventional non-steroidal anti-inflammatory drug. | 2007 Jan-Feb |
|
Comparison of plasma malondialdehyde, glutathione, glutathione peroxidase, hydroxyproline and selenium levels in patients with vitiligo and healthy controls. | 2008 |
|
Extracellular matrix and HIF-1 signaling: the role of prolidase. | 2008 Mar 15 |
|
4-chloroprolines: synthesis, conformational analysis, and effect on the collagen triple helix. | 2008 May |
|
Conformational preferences of substrates for human prolyl 4-hydroxylase. | 2008 Sep 9 |
|
Origin of the stability conferred upon collagen by fluorination. | 2009 Jul 15 |
|
Stereoselective synthesis and biological evaluations of novel 3'-deoxy-4'-azaribonucleosides as inhibitors of hepatitis C virus RNA replication. | 2009 Jul 9 |
|
Direct and continuous assay for prolyl 4-hydroxylase. | 2009 Mar 15 |
|
Quantum mechanical and NMR studies of ring puckering and cis/trans-rotameric interconversion in prolines and hydroxyprolines. | 2009 Oct 8 |
|
The aberrance of the 4S diastereomer of 4-hydroxyproline. | 2010 Aug 11 |
|
Prolidase-dependent regulation of TGF β (corrected) and TGF β receptor expressions in human skin fibroblasts. | 2010 Dec 15 |
|
Immunostimulatory activities of Bacillus simplex DR-834 to carp (Cyprinus carpio). | 2010 Sep |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
27181-7
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
2451-3
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
13374-4
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
56939-2
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
59392-1
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
NCI_THESAURUS |
C29596
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
53153-3
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
2445-5
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
13763-8
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
CFR |
21 CFR 862.1400
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
15135-7
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
20647-4
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
17001-9
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
47651-5
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
2447-1
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
53154-1
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
26810-2
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
28601-3
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
13996-4
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
53393-5
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
11049-4
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
44386-1
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
DSLD |
1137 (Number of products:1)
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
26740-1
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
53397-6
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
6710-8
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
2446-3
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
14785-0
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
25110-8
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
DSLD |
1769 (Number of products:28)
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
59383-0
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
12720-9
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
53152-5
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
32250-3
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
25935-8
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
13401-5
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
26596-7
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
25934-1
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
15143-1
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
||
|
LOINC |
32249-5
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB08847
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
1311548
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | RxNorm | ||
|
6912-67-0
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
18095
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
18240
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
Hydroxyproline
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
DTXSID10883225
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
46704
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
4272
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
51-35-4
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
100000151964
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
20392
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
SUB126409
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
D006909
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
m6148
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | Merck Index | ||
|
C76144
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
200-091-9
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
RMB44WO89X
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
58419
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
RMB44WO89X
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
5810
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY | |||
|
SUB129244
Created by
admin on Fri Dec 15 15:10:53 GMT 2023 , Edited by admin on Fri Dec 15 15:10:53 GMT 2023
|
PRIMARY |
ACTIVE MOIETY